Renovorx Inc (RNXT)

Jul 23, 2025

What analysts say about RenovoRx Inc. stockSignificant capital appreciation - Autocar Professional

Jul 23, 2025

Jul 22, 2025

What drives RenovoRx Inc. stock priceFree Market Dynamics Reports - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Is RenovoRx Inc. a good long term investmentTurbocharged investment results - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

RenovoRx Inc. Stock Analysis and ForecastFree Investment Timing Strategies - jammulinksnews.com

Jul 22, 2025

Jul 19, 2025

RenovoRx (NASDAQ:RNXT) Upgraded to Hold at Wall Street Zen - Defense World

Jul 19, 2025

Jul 17, 2025

What makes RenovoRx Inc. stock price move sharplyFree Premium Stock Market Reports - Newser

Jul 17, 2025

Jul 15, 2025

Why RenovoRx Inc. stock attracts strong analyst attentionHigh Reward Risk Balanced Trading - Newser

Jul 15, 2025

Jul 15, 2025

How RenovoRx Inc. stock performs during market volatilityFast Gains With Reduced Risk - Newser

Jul 15, 2025

Jul 14, 2025

RenovoRx to Host Second Quarter 2025 Financial Results and Business Highlights Conference Call on August 14th at 4:30 p.m. ET - BioSpace

Jul 14, 2025

Jul 14, 2025

RenovoRx to Host Second Quarter 2025 Financial Results and Business Highlights Conference Call on August 14 - Business Wire

Jul 14, 2025

Jul 08, 2025

RenovoRx (NASDAQ:RNXT) Trading Down 2.9% – Should You Sell? - Defense World

Jul 08, 2025

Jul 01, 2025

Will RenovoRx (NASDAQ:RNXT) Spend Its Cash Wisely? - Yahoo Finance

Jul 01, 2025

Jun 25, 2025

RenovoRx shareholders elect directors and approve incentive plan amendments - Investing.com

Jun 25, 2025

Jun 25, 2025

RenovoRx Stockholders Approve Key Proposals at Annual Meeting - TipRanks

Jun 25, 2025

Jun 16, 2025

Short Interest in RenovoRx, Inc. (NASDAQ:RNXT) Declines By 35.4% - Defense World

Jun 16, 2025

Jun 12, 2025

Citadel Advisors LLC Invests $49,000 in RenovoRx, Inc. (NASDAQ:RNXT) - Defense World

Jun 12, 2025

Jun 10, 2025

RenovoRX chief medical officer buys $29,399 in common stock By Investing.com - Investing.com Canada

Jun 10, 2025

Jun 09, 2025

RenovoRX chief medical officer buys $29,399 in common stock - Investing.com Australia

Jun 09, 2025

Jun 09, 2025

Insider Buying: Ramtin Agah Acquires Additional Shares of RenovoRx Inc (RNXT) - GuruFocus

Jun 09, 2025

Jun 08, 2025

RenovoRx (NASDAQ:RNXT) Stock Rating Upgraded by Wall Street Zen - Defense World

Jun 08, 2025

Jun 06, 2025

RenovoRx (NASDAQ:RNXT) Given New $11.50 Price Target at Ascendiant Capital Markets - Defense World

Jun 06, 2025

Jun 06, 2025

RenovoRx (RNXT) PT Raised to $11.50 by Ascendiant on Strong Q1 2025 Results - Yahoo Finance

Jun 06, 2025

Jun 05, 2025

Ascendiant Capital raises RenovoRx stock price target to $11.50 By Investing.com - Investing.com Canada

Jun 05, 2025